NEW YORK TIMES: Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug

Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug





CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed by insurance that disrupt treatments for patients. By Rebecca Robbins and Reed Abelson from NYT (New York Times) Health
Read more.

Leave a Reply